O-Ray Pharma is categorized under Research and Development Laboratories in Pasadena, CA and active since 2006.
O-Ray Pharma was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact William H Slattery at the company’s single location by writing to 2285 East Foothill Boulevard, Pasadena, California CA 91107 or by phoning (617) 596-9080. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | O-Ray Pharma |
| Contact Person: | William H Slattery |
| Address: | 2285 East Foothill Boulevard, Pasadena, California 91107 |
| Phone Number: | (617) 596-9080 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
O-Ray Pharma was started in 2006 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact William H Slattery for inquiries that concern O-Ray Pharma by calling the company number (617) 596-9080, as your correspondence is most welcome. Additionally, the physical location of the single location of O-Ray Pharma can be found at the coordinates 34.149698,-118.103223 as well as the street address 2285 East Foothill Boulevard in Pasadena, California 91107.
For its online presence, you may visit O-Ray Pharma’s website at and engage with its social media outlets through on Twitter and on Facebook.